Sylvamo director granted 7,623 RSUs as board pay
Sylvamo Corp director David D. Petratis received an equity award rather than buying shares on the market.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sylvamo Corp director David D. Petratis received an equity award rather than buying shares on the market. He was granted 7,623 common-share–equivalent restricted stock units at a reference price of $38.70 per share, increasing his direct holdings to 35,106 shares. The grant covers service for the 2026-2027 performance year. The award consists of 3,876 time-based RSUs and 3,747 RSUs taken in lieu of a cash retainer, which will convert one-for-one into common stock on the earlier of May 13, 2027, or the next annual shareowners meeting. Settlement of the vested RSUs is deferred until the earlier of May 13, 2032, or the end of his board service.
Insights
Routine director equity grant; compensation-related, not a market purchase.
Director David D. Petratis received 7,623 restricted stock units, tied to his 2026-2027 board service, at a reference price of $38.70 per share. This is standard equity-based compensation rather than an open-market trade.
The award mixes 3,876 time-based RSUs and 3,747 RSUs in lieu of a cash retainer, aligning director pay with shareholder value. Vesting occurs on the earlier of May 13, 2027 or the next annual meeting, with settlement deferred to as late as May 13, 2032.
Such deferred RSU programs are common for boards, smoothing compensation and encouraging longer-term alignment. The filing shows his direct holdings rising to 35,106 shares after the grant, but does not indicate any discretionary buying or selling activity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 7,623 | $38.70 | $295K |
Footnotes (1)
- F1. The reported securities represent 3,876 time-based restricted stock units ("RSUs") and 3,747 RSUs that the reporting person elected to receive in lieu of a cash retainer. The RSUs will vest one-for-one in common stock on the earlier of May 13, 2027, or the next annual shareowners meeting. The reporting person has elected to defer the settlement of vested RSUs until the first to occur of May 13, 2032, or the termination of his service as a director. The RSUs were granted to the reporting person on May 15, 2026, for service as a director for the 2026-2027 performance year.
Key Figures
Key Terms
restricted stock units financial
cash retainer financial
vest financial
defer the settlement financial
performance year financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Sylvamo (SLVM) report for David D. Petratis?
What are the terms of the Sylvamo (SLVM) RSU grant to director Petratis?
Was the Sylvamo (SLVM) Form 4 a stock purchase or a compensation grant?
At what reference price were the Sylvamo (SLVM) RSUs granted to Petratis?
AI-generated analysis. How Rhea-AI works. Not financial advice.